Меню
Набор скоро начнётся NCT07698418

Effect of Inspiratory Muscle Training on Knee Osteoarthritis Pain

Без фазы С лечением Knee Osteoarthritis Knee Osteoarthritis (Knee OA)

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Inspiratory muscle training, Sham inspiratory muscle training.
Кому может быть актуально
Состояния в реестре: Knee Osteoarthritis, Knee Osteoarthritis (Knee OA). Базовые параметры: 55 лет — 80 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Список центров уточняется — проверьте первичный протокол.
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Effect of Inspiratory Muscle Training on Pain in Patients With Knee Osteoarthritis: A Randomized Controlled Trial

Обзор

Knee osteoarthritis (KOA) is a common joint disease that causes chronic pain and limits daily activities. Current treatments, such as painkillers or surgery, have limitations like side effects or high costs. This study will test whether a safe, non-drug intervention-inspiratory muscle training (breathing exercises against resistance)-can reduce knee pain in people with KOA. The training may work by lowering inflammation and improving the brain's modulation of pain. Eighty patients aged ≥55 years with confirmed KOA and frequent knee pain will be enrolled. Participants will be randomly assigned to either an 8-week inspiratory muscle training program (5 sessions per week, with gradually increasing resistance) or a sham (very low resistance) training program. Neither the patients nor the researchers assessing the outcomes will know who is in which group. The main outcome is change in knee pain measured by a visual analog scale (VAS). Secondary outcomes include blood markers of inflammation (TNF-α, IL-6, IL1β), physical function, the Knee injury and Osteoarthritis Outcome Score (KOOS), inspiratory muscle strength, activity level, sleep quality, and quality of life. To explore underlying mechanisms, outcomes included heart rate variability (HRV) as an indicator of autonomic nervous system function, and brain functional connectivity in the prefrontal cortex using functional near-infrared spectroscopy (fNIRS) are collected. These mechanistic assessments will be performed at baseline and at the end of 8-week intervention. Additional follow-up assessments for clinical outcomes will be done at 3 and 6 months after the training ends. Any side effects or adverse events will be recorded. This study will provide high-quality evidence on whether inspiratory muscle training is an effective and safe complementary treatment for knee pain in people with knee OA, and will offer new insights into the mechanisms underlying its analgesic effects.

Вмешательства

  • Другое Inspiratory muscle training
    Participants will perform home-based inspiratory muscle training using a threshold-loading device (POWERbreathe Medic Plus). Training is conducted 5 times per week for 8 weeks. The initial inspiratory load is set at 50% of the individual's maximum inspiratory pressure (MIP), measured weekly at the study site. The load is progressively increased to 80% MIP over the first 4 weeks and maintained at 80% MIP for the remaining 4 weeks. Each session consists of 40-60 breaths. Adherence is monitored via
  • Другое Sham inspiratory muscle training
    Participants will perform home-based inspiratory muscle training using a threshold-loading device (POWERbreathe Medic Plus). Training is conducted 5 times per week for 8 weeks. The initial inspiratory load is set at 10% of the individual's maximum inspiratory pressure (MIP), measured weekly at the study site. The load is maintained 10% MIP over 8 weeks. Each session consists of 40-60 breaths. Adherence is monitored via an electronic training log and weekly on-site visits.

Первичные конечные точки

  • Visual analogue scale [Срок оценки: Baseline, week 8, 3-month after intervention, 6-month after intervention]
Вторичные конечные точки (10)
  • The Knee injury and Osteoarthritis Outcome Score [Срок оценки: Baseline, week 8, 3-month after intervention, 6-month after intervention]
  • Serum levels of inflammatory markers [Срок оценки: Baseline, up to week 8]
  • Heart rate variability [Срок оценки: Baseline, up to week 8]
  • Prefrontal cortex activity [Срок оценки: Baseline, up to week 8]
  • 40-meter walk test [Срок оценки: Baseline, up to week 8]
  • 30-sec chair stand test [Срок оценки: Baseline, up to week 8]
  • Physical Activity Scales for the Elderly [Срок оценки: Baseline, week 8, 3-month after intervention, 6-month after intervention]
  • Pittsburgh Sleep Quality Index [Срок оценки: Baseline, week 8, 3-month after intervention, 6-month after intervention]
  • 12-Item Short Form Health Survey [Срок оценки: Baseline, week 8, 3-month after intervention, 6-month after intervention]
  • Maximal inspiratory pressure [Срок оценки: Baseline, up to week 8]

Критерии участия

Критерии включения

  • Aged 55 years or older.
  • Knee osteoarthritis (Kellgren-Lawrence grade ≥ 2).
  • Knee pain (Visual Analogue Scale, VAS ≥ 3) on the most days in the past month.
  • Able to walk independently without assitive devices.

Критерии исключения

  • History of knee replacement surgery, meniscus surgery, or ligament surgery.
  • Received corticosteroid injection within the previous three weeks.
  • Diagnosed with rheumatoid arthritis.
  • Unstable angina, recent myocardial infarction, uncontrolled cardiac arrhythmia, or severe heart failure.
  • History of stroke.
  • Currently receiving steroid therapy, hormonal therapy, or cancer chemotherapy.
  • Pneumothorax, pulmonary bullae, lung surgery within the past 12 months, unstable asthma, or severe dyspnea at rest.
  • Unable to understand the study procedures and potential risks.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Тройное слепое
Основная цель
Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT07698418 · ZHSC-1-(2026)014

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗